Key result
Anti-mitochondrial M2 antibodies linked to eosinophilic myocarditis and myositis, suggesting mitochondrial damage triggers inflammation.
Why the study?
The mechanism underlying eosinophilic myocarditis associated with anti-mitochondrial M2 antibodies and its link to myocarditis onset was unclear.
Case Report (n=1)
Anti-mitochondrial M2 antibodies may drive eosinophilic myocarditis and myositis via immune reactions against PDC-E2 released from damaged mitochondria.
Answers are grounded in this paper and cite their sources.
May warrant anti-M2 antibody testing in eosinophilic myocarditis with myositis; hypothesis-generating for mitochondrial PDC-E2 as inflammatory trigger.
A 68-year-old woman was diagnosed with eosinophilic myocarditis. Laboratory tests showed abnormally increased eosinophils (50.2%) on the leucocyte counts (17 600 /μL). An endomyocardial biopsy (EMB) was performed from the right ventricular septum and revealing numerous eosinophilic infiltrations. Immediately after starting prednisolone 30 mg/day, her eosinophil count normalized, we gradually decreased treatment. Three months later, she became aware of poor mobility in her right lower limb when prednisolone reduced to 5 mg. Femoral magnetic resonance imaging revealed a high-intensity area in her right biceps femoris muscle by short T1 inversion recovery method (Panel A, arrows). Testing for relevant antibodies showed positivity for anti-mitochondrial M2 only, prompting a diagnosis of myositis with anti-mitochondrial M2 antibody. Skeletal muscle biopsy was performed. Immunohistochemistry for pyruvate dehydrogenase complex-E2 subunit (PDC-E2), an antigen for anti-mitochondrial M2 antibodies, showed granular cytoplasmic staining in myocytes (Panel B). We also performed immunohistochemistry for PDC-E2 in the previous EMB samples, and found granular staining in the cytoplasm of all cardiomyocytes (Panel C). Reviewing the electron microscopy of EMB samples revealed degenerated mitochondria (Panel D, arrows) in cardiomyocytes. Comparable samples from a patient with eosinophilic myocarditis negative for anti-mitochondrial M2 antibodies revealed no immunostaining for myocardial PDC-E2 (Panel E). Myositis with anti-mitochondrial M2 antibodies is characterized by high frequency of cardiac involvement, similar to myocarditis. Mitochondrial damage released PDC-E2 into the cytoplasm, prompting inflammatory activation against those damaged cells. The presence of such immune reactions in cardiomyocytes and skeletal muscle could result in myocarditis and myositis, respectively, as seen in the present patient.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2018) conducted a case report in Eosinophilic myocarditis and myositis (n=1). Anti-mitochondrial M2 antibodies was evaluated. In a 68-year-old woman, eosinophilic myocarditis and subsequent myositis were associated with anti-mitochondrial M2 antibodies, suggesting mitochondrial damage triggers inflammatory activation.
Synapse has enriched 10 related papers. Consider them for comparative context: